Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Calypte Awarded SFDA Approval of Oral HIV Diagnostic Test

publication date: Apr 18, 2008

Calypte Biomedical Corporation of Portland, OR received SFDA approval for its oral HIV diagnostic test, Aware™ HIV-1/2 OMT (oral fluid). The test delivers results in 20 minutes with an accuracy comparable to lab tests. Aware is the only rapid oral fluid test approved for use in China. The test is being positioned as an alternative HIV test for medical sites that do not have access to a lab. The test is effective in detecting HIV-1 and HIV-2. More details...

Stock Symbols: (OTCBB: CBMC)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here